Table 1.
Baseline clinical and pathological characteristics of the 87 patients enrolled in the study.
| Patient characteristics | Category/Class | Count (n=24) | Rate (%) |
|---|---|---|---|
| Age (y), median (range) | 57(29–77) | ||
| Gender | Female | 52 | 59.8 |
| Male | 35 | 40.2 | |
| Body weight | 57(37–82.5) | ||
| BSA (m2) | 1.59(1.24–1.92) | ||
| Smoking status | Never | 57 | 65.5 |
| Former | 16 | 18.4 | |
| Present | 14 | 16.1 | |
| Clinical stage (UICC) | III | 24 | 27.6 |
| IV | 63 | 72.4 | |
| ECOG PS | 0 | 34 | 39.1 |
| 1 | 48 | 55.2 | |
| 2 | 5 | 5.7 | |
| EGFR mutation status | Exon 19 deletion | 58 | 66.7 |
| Exon 21 L858R | 29 | 33.3 |
BSA, body surface area; ECOG PS, eastern cooperative oncology group performance status; EGFR, epidermal growth factor receptor.